<b>Elsafty_Reports_of_Myeloid_Neoplasms_2024</b>

The online platform (https://cbctst.com) was used to automatically generate comprehensive clinicopathologic correlations including narrative comment/interpretation for CBC and peripheral blood smear review, diagnosis/follow-up, prognosis (molecular studies by NGS/PCR), and recommendations. Elsafty_Reports_of_Myeloid_Neoplasms_2024 provides specialized, world-class, and comprehensive templates for myeloid neoplasms that serve purposes in Hematopathology clinical practice, teaching/training/examination, and automation, including verification and validation of relevant automated systems. This validated, up-to-date, 100% accurate, machine-readable, and novel/unprecedented dataset has been meticulously reviewed word-by-word by both Hematopathologists and attending physicians from various specialties who detect or diagnose such cases at multiple international medical centres. Such meticulous review, referencing the WHO 5th edition, the international consensus classification of myeloid neoplasms and acute leukemias, along with other relevant esteemed publications, justifies the complexity and diversity of the dataset while maintaining benchmark scientific quality.本研究依托在线平台（https://cbctst.com）自动生成全面的临床病理相关性分析内容，涵盖全血细胞计数（CBC）与外周血涂片（peripheral blood smear）复核、诊断/随访、预后评估（基于下一代测序（NGS）/聚合酶链式反应（PCR）的分子检测）及诊疗建议的叙述性评论与解读。 《Elsafty髓系肿瘤报告2024》（Elsafty_Reports_of_Myeloid_Neoplasms_2024）为髓系肿瘤（myeloid neoplasms）提供了专业化、世界级且全面的模板，可应用于血液病理学（Hematopathology）临床实践、教学/培训/考核以及自动化流程，包括相关自动化系统的验证与确认。 这份经过验证、与时俱进、100%准确、可机器读取且新颖且前所未有的数据集，已由来自多个专科的血液病理学家及主治医师逐字审慎审核——这些医师在多家国际医疗中心负责此类病例的检出与诊断工作。 本次审慎审核参考了世界卫生组织（WHO）第五版分类标准、髓系肿瘤与急性白血病国际共识分类，以及其他相关权威出版物，既保障了数据集的复杂性与多样性，同时维持了标杆级的科学质量。